Olmesartan Medoxomil Aurobindo

Olmesartan Medoxomil, the active ingredient in Olmesartan Medoxomil Aurobindo, is an Angiotensin II Receptor Blocker (ARB) presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomil Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomil Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Medoxomil is an antihypertensive agent that acts on the renin‑angiotensin‑aldosterone system to lower blood pressure. - Hypertension: helps achieve and maintain target blood pressure levels in adults. - Diastolic heart failure: may be used as part of combination therapy to improve cardiac function. - Chronic kidney disease with proteinuria: contributes to slowing progression of renal impairment when used with other antihypertensives.

Olmesartan Medoxomil is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhoea

Serious or Rare Side Effects: - Angio‑edema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevation (transaminase rise)

Olmesartan Medoxomil should be used cautiously. - Monitor    :  C  ​                                                                                                                  ​                                                                                                                                                                                                                                                                      ​ - Renal function:  Assess  baseline  and  periodically  especially  in  patients  with  renal  impairment. - Electrolyte balance:  Check  serum  potassium  levels  periodically. - Pregnancy  :  Avoid  use  during  the  second  and  third  trimesters  due  to  potential  fetal  harm. - Breast  :  Caution  if  maternal  exposure  may  affect  infants  through  breeding  milk. - Drug                                                                                                                                                                                                                                                                                                                                                                                                                                          ​ - Store at  Below  Below  Below  Below  Below  Below  Below  Below   -   -  

The               …  ...  ....  …  … …  ....  …  …